SONIA BAHROO: Open Payments
NPI 1053367441 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,321 in 35 payments from 16 companies in 2025. Trend: 2023 $1,657 · 2024 $1,315 · 2025 $1,321
Food & beverage: $1,321
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $217 |
| BETA BIONICS, INC. | 2 | $217 |
| Lilly USA, LLC | 8 | $181 |
| Abbott Laboratories | 4 | $164 |
| CeQur Corporation | 1 | $98 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $94 |
| Sequel Med Tech, LLC | 2 | $56 |
| RECORDATI_RARE_DISEASES_INC. | 2 | $46 |
| Xeris Pharmaceuticals, Inc. | 2 | $45 |
| ABBVIE INC. | 2 | $42 |
Products named: Korlym, iLet Bionic Pancreas, JARDIANCE, FREESTYLE LIBRE 3, CeQur Simplicity, TWIIST, ISTURISA, GVOKE HYPOPEN.
Industry payments across DC — which companies pay providers there.
